DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20210455

Synchronous phyllodes tumor and invasive breast carcinoma in contralateral breasts- a rare case report

Michelle Mathias, Divya Joshi, Kishan Prasad H. L., Sajitha K., Lancet Lobo, Abena Hidangmayum

Abstract


Phyllodes tumours are rare breast tumours, accounting for 0.3-1% of all breast cancers and 2.5% of fibroepithelial tumours. They occur in younger age women in Asian countries. These can be classified into benign, borderline and malignant based on stromal hypercellularity, mitotic figures, cellular pleomorphism, stromal overgrowth and nature of the tumour borders. Synchronous coexistence of phyllodes tumour and invasive breast carcinoma in the contralateral breast is very rare, and probably the second one reported in the literature. Hereby, we report a case of a middle-aged woman presenting with a lump in the bilateral breast, diagnosed to have benign phyllodes of one breast and Invasive carcinoma of the contralateral breast.


Keywords


Phyllodes tumor, Carcinoma breast, Synchronous, Carcinoma thyroid

Full Text:

PDF

References


Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Vijver MJ: WHO Classification of Tumours of the Breast. 4th edition. IARC Press, Lyon, 2012

Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW: Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007;5:324–30.

Grove A, Deibjerg Kristensen L: Intraductal carcinoma within a phyllodes tumor of the breast: a case report. Tumori. 1986;72:187–190.

Neto GB, Rossetti C, Souza NA, Fonseca FL, Azzalis LA, Junquiera VBC, et al. Coexistence of benign phyllodes tumor and invasive ductal carcinoma in distinct breasts: case report. Europ J Medic Re. 2012;17:8.

Schwentner L, Kurzeder C, Kreienberg R, Wockel A. Focus on Hematogenous dissemination of malignant cystosarcoma phyllodes:institutional experience. Arch Gynecol Obstet. 2011;283(3):591-6

Tan PH, Thike AA, Tan WJ. Predicting clinical behaviour of breast phyllodes tumors: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69-76

Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000,89:1502–11.

Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68:5–21.

Hung CC, Yeh DC, Lee CH, Wu CC, Liu TJ. Invasive ductal carcinoma raising in borderline phyllodes tumor. Formos J Surg. 2015;48:65-7.

Jain S, Kaur R, Agarwal R, Chopra P. Bilateral invasive ductal carcinoma, phyllodes tumor and multiple fibroadenomas of breast associated with lymph node metastases- rare coexistence. Ind J Surg Oncol. 2014;5(3):186–8

To H, Ong BS, Dodd T, Prasannan S. Synchronous malignant phyllodes tumor and invasive lobular carcinoma – case report and review. J Surgic Case Rep. 2018;10:1–4

Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16:64–7.

Ikeda Y, Kiyotani K, Yew PY, Kato T, Tamura K, Yap K, et al. Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocr Relat Cancer. 2016;23(3):171–9.

Tucker MA, Jones PH, Boice JD Jr, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res. 1991;51:2885–8.